A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the long term safety and efficacy of TAK-385, once
daily (QD) following continued administration in participants who completed a Phase II
dose-finding study.